Catalyst Wire Dossier Catalyst Wire Dossier

GMRx2

· George Medicines PTY Limited
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for GMRx2, covering 2025-06-03 to 2025-06-03. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of GMRx2 Compared to Placebo for the Treatment of Hypertension [Phase 3]

See pricing